Tel: +61 3 990 39528
Fax: +61 3 990 39052
Email: Michael.Campbell@monash.edu
Web: http://www.pharm.monash.edu.au/research/mips/cdco/index.html
Position
Chemistry team leader
Centre for Drug Candidate Optimisation
Monash Institute of Pharmaceutical Sciences
Charman, S., Arbe-Barnes, S., Bathurst, I., Brun, R., Campbell, M., Charman, W., Chiu, F., Chollet, J., Craft, C., Creek, D., Dong, Y., Matile, H., Maurer, M., Morizzi, J., Nguyen, T., Papastogiannidis, P., Scheurer, C., Shackleford, D., Sriraghavan, K., Stingelin, L., Tang, Y., Urwyler, H., Wang, X., White, K., Wittlin, S., Zhou, L., Vennerstrom, J., 2011, Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria, Proceedings Of The National Academy Of Sciences Of The United States Of America [P], vol 108, issue 11, National Academy of Sciences, Washington D.C., USA, pp. 4400-4405.
El Maghraby, G.M.M., Campbell, M., Finnin, B.C., 2005, Mechanisms of action of novel skin penetration enhancers: phospholipid versus skin lipid liposomes, International Journal of Pharmaceutics, vol 305, issue 1-Feb, Elsevier, The Netherlands, pp. 90-104.
Campbell, M., Prankerd, R.J., Davie, A.S., Charman, W.N., 2004, Degradation of berenil (diminazene aceturate) in acidic aqueous solution, Journal of Pharmacy and Pharmacology, vol 56, issue 10, Pharmaceutical Press, London UK, pp. 1327-1332.
McIntosh, M.P., Charman, W.N., Campbell, M., Porter, C.J.H., 2004, Influence of physicochemical properties on the patterns of association of a series of aliphatic esters of halofantrine with plasma lipoproteins, Journal of Controlled Release, vol 95, issue 2, Elsevier, The Netherlands, pp. 275-289.
Kok, G.B., Campbell, M., Mackey, B., Von Itzstein, M., 2001, Synthesis of C-3 nitrogen-containing derivatives of N-acetyl-,-D-mannosamine as substrates for N-acetylneuraminic acid aldolase, Carbohydrate Research, vol 332, Elsevier Science Ltd, Oxford UK, pp. 133-139.
Affiliations with institutes
Centre for Drug Candidate Optimisation
Chemistry team leader
Monash Institute of Pharmaceutical Sciences
Authorised by: Director, Office of Marketing and Communications.
Maintained by: eSolutions ServiceDesk.
Last updated: 18 February 2013.
Copyright © 2013 Monash University. ABN 12 377 614 012 -
Accessibility -
Caution -
Privacy
CRICOS Provider Number: 00008C
We acknowledge and pay respects to the Elders and Traditional Owners of the land on which our six Australian campuses stand. Information for Indigenous Australians
